MEDICINES CONTROL COUNCIL NOTIFICATION OF REGISTRATION OF MEDICINES BY THE REGISTRAR IN TERMS OF SECTION 17 OF THE MEDICINES AND RELATED SUBSTANCES ACT 101 OF 1965 Application Number Holder of registration of Certificate Proprietary Name Active Compound 01/21.1/11 SCHERING-PLOUGH 03/3.1/1 SCHERING-PLOUGH 03/3.1/2 SCHERING-PLOUGH 03/3.1/3 SCHERING-PLOUGH FLORVETOL ZUBRIN 30 MG ZUBRIN 50 MG ZUBRIN 100 MG EACH 1,0 ml SOLUTION FLORFENICOL 300,0 TEPOXALIN 30,0 TEPOXALIN 50,0 TEPOXALIN 100,0 03/3.1/4 SCHERING-PLOUGH 03/2.6/12 BAYER, ANIMAL HEALTH DIVISION ZUBRIN 200 MG FLUXAVET INJECTION 34/10.2.1/0076 PHARMACARE VENTEZE EASYHALER FORTE 34/7.1.3/0233 PFIZER LABORATORIES ACCUMAX CO 10/12,5 TEPOXALIN 200,0 EACH 1,0 ml SOLUTION FLUNIXIN MEGLUMINE FLUNIXIN 50,0 EACH DOSE SALBUTAMOL SULPHATE SALBUTAMOL 200,0 ug QUINAPRIL QUINAPRIL 10,0 12.22 Notification of registration 3 Jun 2005v3.doc - Feb 2006 Page 1 of 11
34/7.1.3/0234 PFIZER LABORATORIES 36/1.2/0158 HEXAL PHARMA (SA) 36/1.2/0159 HEXAL PHARMA (SA) 36/1.2/0160 HEXAL PHARMA (SA) 36/1.2/0161 HEXAL PHARMA (SA) 36/21.8/0197 WYETH SOUTH AFRICA 36/21.8/0198 WYETH SOUTH AFRICA 36/8.4/0209 B.BRAUN MEDICAL (PTY) 36/8.4/0210 B.BRAUN MEDICAL (PTY) 36/20.1.2/0290 NORBROOK LABORATORIES SA 36/21.5.1/0390 IVAX S.A. ACCUMAX CO 20/12,5 QUINAPRIL QUINAPRIL 20,0 PARAX 20 PAROXETINE PAROXETINE 20,0 PARAX 40 PAROXETINE PAROXETINE 40,0 HEXAL-PAROXETINE 20 PAROXETINE HEXAL-PAROXETINE 40 PREMELLE LD-0,3/1,5 PREMELLE LD-0,45/1,5 HEMOHES 6% HEMOHES 10% NORBROOK FLUCLOXACILLIN FOR INJECTION BECEZE 50 EASI BREATHE CFC FREE PAROXETINE 20,0 PAROXETINE PAROXETINE 40,0 CONJUGATED OESTROGEN 0,3 MEDROXYPROGESTERONE ACETATE 1,5 CONJUGATED OESTROGEN 0,45 MEDROXYPROGESTERONE ACETATE 1,5 EACH 1000,0 ml SOLUTION HYDROXYETHYL STARCH 60,0 g SODIUM CHLORIDE 9,0 g EACH 1000,0 ml SOLUTION HYDROXYETHYL STARCH 100,0 g SODIUM CHLORIDE 9,0 g EACH VIAL FLUCLOXACILLIN SODIUM FLUCLOXACILLIN 500,0 EACH METERED DOSE BECLOMETHASONE DIPROPIONATE 50,0 ug 36/21.5.1/0391 IVAX S.A. BECEZE 100 EASI BREATHE CFC FREE EACH METERED DOSE BECLOMETHASONE DIPROPIONATE 100,0 ug 12.22 Notification of registration 3 Jun 2005v3.doc - Feb 2006 Page 2 of 11
36/21.5.1/0392 IVAX S.A. BECEZE 250 EASI BREATHE CFC FREE EACH METERED DOSE BECLOMETHASONE DIPROPIONATE 250,0 ug 36/20.1.1/0424 PHARMACARE THROSYN 150 MG TABLET ROXITHROMYCIN 150,0 36/2.2/0426 XIXIA ZOPIGEN ZOPICLONE 7,5 36/2.2/0447 SANDOZ Z-DORM HS ZOPICLONE 3,75 36/15.4/0476 PHARMACARE GLAUCARE 0,25% EACH 1,0 ml SOLUTION TIMOLOL MALEATE TIMOLOL 2,5 36/15.4/0477 PHARMACARE GLAUCARE 0,5% EACH 1,0 ml SOLUTION TIMOLOL MALEATE TIMOLOL 5,0 37/12/0008 ADCO-WORMEX 500 MG MEBENDAZOLE 500,0 37/12/0009 RIOWORM 500 MG MEBENDAZOLE 500,0 37/2.8/0060 SANDOZ IBUPAIN FORTE EACH CAPSULE PARACETAMOL 250,0 IBUPROFEN 200,0 CODEINE PHOSPHATE 10,0 37/2.8/0133 SANDOZ IBUPAIN EACH CAPSULE 37/2.8/0134 SANDOZ SANDOPAIN CAPSULES 37/2.8/0135 SANDOZ SANDOPAIN FORTE CAPSULES 37/7.1.3/0160 37/7.1.3/0161 37/7.1.3/0162 ZETOMAX CO 10/12,5 ZETOMAX CO 20/25 ZETOMAX CO 20/12,5 PARACETAMOL 250,0 IBUPROFEN 200,0 EACH CAPSULE IBUPROFEN 200,0 PARACETAMOL 250,0 EACH CAPSULE IBUPROFEN 200,0 PARACETAMOL 250,0 CODEINE PHOSPHATE 10,0 LISINOPRIL DIHYDRATE LISINOPRIL 10,0 LISINOPRIL DIHYDRATE LISINOPRIL 20,0 HYDROCHLOROTHIAZIDE 25,0 LISINOPRIL DIHYDRATE LISINOPRIL 20,0 12.22 Notification of registration 3 Jun 2005v3.doc - Feb 2006 Page 3 of 11
37/34/0169 HEXAL PHARMA (SA) 37/34/0170 HEXAL PHARMA (SA) 37/34/0171 HEXAL PHARMA (SA) 37/34/0172 HEXAL PHARMA (SA) 37/34/0173 HEXAL PHARMA (SA) 37/34/0174 HEXAL PHARMA (SA) 37/34/0175 HEXAL PHARMA (SA) 37/34/0176 HEXAL PHARMA (SA) 37/34/0177 HEXAL PHARMA (SA) 37/34/0178 HEXAL PHARMA (SA) ETOPOSIDE-HEXAL 50 EACH 2,5 ml SOLUTION MG/2,5 ETOPOSIDE 50,0 ETOPOSIDE-HEXAL 100 MG/5,0 ETOPOSIDE-HEXAL 200 MG/10 ETOPOSIDE-HEXAL 400 MG/20 ETOPOSIDE-HEXAL 1000 MG/50 HX-ETOPOSIDE 50 MG/2,5 HX-ETOPOSIDE 100 MG/5,0 HX-ETOPOSIDE 200 MG/10 HX-ETOPOSIDE 400 MG/20 HX-ETOPOSIDE 1000 MG/50 37/3.1/0232 SANDOZ SANDOZ MELOXICAM 7,5 37/3.1/0233 SANDOZ SANDOZ MELOXICAM 15 37/30.2/0252 ABBOTT LABORATORIES HUMIRA 40 MG S.A. 37/1.2/0265 ZYDUS HEALTHCARE SA 37/7.1.3/0276 PHARMA DYNAMICS 37/7.1.3/0277 PHARMA DYNAMICS 37/7.1.3/0278 PHARMA DYNAMICS 37/7.1.3/0279 PHARMA DYNAMICS 37/7.1.3/0280 PHARMA DYNAMICS 37/7.1.3/0281 PHARMA DYNAMICS 37/5.7.2/0312 AUSTELL LABORATORIES (PTY) ZYDUS-FLUOXETINE 20 MG CARVETREND 6,25 MG CARVETREND 12,25 MG CARVETREND 25 MG PHARMA DYNAMICS CARVEDILOL 6,25 MG PHARMA DYNAMICS CARVEDILOL 12,5 MG PHARMA DYNAMICS CARVEDILOL 25 MG AUSTELL- METOCLOPRAMIDE 5 MG/ EACH 5,0 ml SOLUTION ETOPOSIDE 100,0 EACH 10,0 ml SOLUTION ETOPOSIDE 200,0 EACH 20,0 ml SOLUTION ETOPOSIDE 400,0 EACH 50,0 ml SOLUTION ETOPOSIDE 1000,0 EACH 2,5 ml SOLUTION ETOPOSIDE 50,0 EACH 5,0 ml SOLUTION ETOPOSIDE 100,0 EACH 10,0 ml SOLUTION ETOPOSIDE 200,0 EACH 20,0 ml SOLUTION ETOPOSIDE 400,0 EACH 50,0 ml SOLUTION ETOPOSIDE 1000,0 MELOXICAM 7,5 MELOXICAM 15,0 EACH 0,8 ml SOLUTION ADALIMUMAB 40,0 EACH CAPSULE FLUOXETINE FLUOXETINE 20,0 CARVEDILOL 6,25 CARVEDILOL 12,25 CARVEDILOL 25 CARVEDILOL 6,25 CARVEDILOL 12,5 CARVEDILOL 25 EACH 1,0 ml SOLUTION METOCLOPRAMIDE 5,0 12.22 Notification of registration 3 Jun 2005v3.doc - Feb 2006 Page 4 of 11
37/20.1.1/0364 AUSTELL LABORATORIES (PTY) 37/20.1.1/0365 AUSTELL LABORATORIES (PTY) Administration 37/20.2.3/0347 MDI CC EBSAR-2 DS RIFAMPICIN 300,0 ISONIAZID 150,0 37/7.1.3/0356 SERVIER BIPRETERAX LABORATORIES SOUTH INDAPAMIDE 1,25 AFRICA PERINDOPRIL TERT- AUSTELL- CEFOTAXIME 0,5 G AUSTELL- CEFOTAXIME 1,0 G 37/20.2.2/0381 SANDOZ SANDOZ- KETOCONAZOLE TABLETS 37/26/0387 HEXAL PHARMA (SA) 37/26/0388 HEXAL PHARMA (SA) HX-EPIRUBICIN 10 MG/5 HX-EPIRUBICIN 50 MG/25 BUTYLAMINE 4,00 EACH VIAL CEFOTAXIME SODIUM CEFOTAXIME 0,5 g EACH VIAL CEFOTAXIME SODIUM CEFOTAXIME 1,0 g KETOCONAZOLE 200,0 EACH 5,0 ml SOLUTION EPIRUBICIN 10,0 EACH 25,0 ml SOLUTION EPIRUBICIN 50,0 37/26/0389 HEXAL PHARMA (SA) 37/26/0390 HEXAL PHARMA (SA) 37/5.7.1/0405 XIXIA 37/30.1/0449 AVENTIS PHARMA (PTY) 37/30.1/0450 AVENTIS PHARMA (PTY) HX-EPIRUBICIN 100 MG/50 HX-EPIRUBICIN 200 MG/100 RHINIGINE TRIGRIP VAXIGRIP NH EACH 50,0 ml SOLUTION EPIRUBICIN 100,0 EACH 100,0 ml SOLUTION EPIRUBICIN 200,0 LORATADINE 10,0 EACH 0,5 ml DOSE A/FUJIAN/411/2002 (H3N2) like STRAIN 15,0 ug A/NEW CALEDONIA/20/99 (H1N1) like STRAIN 15,0 ug B/HONG KONG/330/2001 like STRAIN 15,0 ug EACH 0,5 ml DOSE A/MOSCOW/10/99 (H3N2) like STRAIN 15,0 ug A/NEW CALEDONIA/20/99 (H1N1) like STRAIN 15,0 ug B/HONG KONG/330/2001 like STRAIN 15,0 ug 12.22 Notification of registration 3 Jun 2005v3.doc - Feb 2006 Page 5 of 11
37/3.1/0467 CIPLA-MEDPRO (PTY) 37/3.1/0468 CIPLA LIFE SCIENCES 37/20.2.8/0489 CIPLA-MEDPRO (PTY) 37/8.3/0566 ROCHE PRODUCTS 37/8.3/0567 ROCHE PRODUCTS IBUGESIC ORAL EACH 5,0 ml SUSPENSION SUSPENSION IBUPROFEN 100,0 CIPLA-IBUPROFEN EACH 5,0 ml SUSPENSION ORAL SUSPENSION IBUPROFEN 100,0 LAMIVIR-HBV LAMIVUDINE 100,0 RECORMON 1 000 IU/0,3 EACH SYRINGE EPOETIN BETA 1 000,0 iu RECORMON 2 000 IU/0,3 EACH SYRINGE EPOETIN BETA 2 000,0 iu 37/8.3/0568 ROCHE PRODUCTS RECORMON 4 000 IU/0,3 37/8.3/0569 ROCHE PRODUCTS RECORMON 6 000 IU/0,3 37/20.1.1/0581 HEXAL PHARMA (SA) NORFLOXACIN HEXAL 400 37/20.2.2/0583 LE BASI VARI-FLUCONAZOLE CC 37/3.1/0607 PHARMACARE DICLO-FLAM BLACKCURRANT 37/7.1.3/0631 HEXAL PHARMA (SA) HEXAL-LISINOPRIL CO 10 37/7.1.3/0632 HEXAL PHARMA (SA) 37/7.5/0635 HEXAL PHARMA (SA) 37/7.5/0636 HEXAL PHARMA (SA) 37/7.5/0637 HEXAL PHARMA (SA) 37/7.5/0638 HEXAL PHARMA (SA) 37/7.5/0639 HEXAL PHARMA (SA) 37/7.5/0640 HEXAL PHARMA (SA) 37/11.5/0642 SOLVAY PHARMA (PTY) 37/3.1/0656 PHARMA DYNAMICS HEXAL-LISINOPRIL CO 20 PRAVAHEXAL 10 PRAVAHEXAL 20 PRAVAHEXAL 40 PRANALIP 10 PRANALIP 20 PRANALIP 40 BIFITERAL DRY PHARMA DYNAMICS DICLOFENAC 25 EACH SYRINGE EPOETIN BETA 4 000,0 iu EACH SYRINGE EPOETIN BETA 6 000,0 iu NORFLOXACIN 400,0 EACH CAPSULE FLUCONAZOLE 50,0 DICLOFENAC SODIUM 50,0 LISINOPRIL DIHYDRATE LISINOPRIL 10,0 LISINOPRIL DIHYDRATE LISINOPRIL 20,0 PRAVASTATIN SODIUM 10,0 PRAVASTATIN SODIUM 20,0 PRAVASTATIN SODIUM 40,0 PRAVASTATIN SODIUM 10,0 PRAVASTATIN SODIUM 20,0 PRAVASTATIN SODIUM 40,0 EACH SACHET LACTULOSE 10,0 g DICLOFENAC POTASSIUM 25,0 12.22 Notification of registration 3 Jun 2005v3.doc - Feb 2006 Page 6 of 11
37/3.1/0657 PHARMA DYNAMICS 37/3.1/0658 PHARMA DYNAMICS 37/3.1/0659 PHARMA DYNAMICS 37/2.7/0666 BOOTS HEALTHCARE (SOUTH AFRICA) (PTY) 38/20.1.1/0005 HEXAL PHARMA (SA) DYNAK 50 DICLOFENAC POTASSIUM 50,0 DYNAK 25 DICLOFENAC POTASSIUM 25,0 PHARMA DYNAMICS DICLOFENAC 50 DICLOFENAC POTASSIUM 50,0 NUROFEN PLUS IBUPROFEN 200,0 CODEINE PHOSPHATE 12,8 CLARIHEXAL 250 CLARITHROMYCIN 250,0 38/20.1.1/0006 HEXAL PHARMA (SA) CLARIHEXAL 500 CLARITHROMYCIN 500,0 38/20.1.1/0007 HEXAL PHARMA (SA) 38/20.1.1/0008 HEXAL PHARMA (SA) 38/7.1.3/0025 EGIS SOUTH AFRICA (PTY) 38/7.1.3/0026 EGIS SOUTH AFRICA (PTY) 38/7.1.3/0027 BIOGARAN SOUTH AFRICA 38/7.1.3/0028 BIOGARAN SOUTH AFRICA 38/21.8.2/0055 MEDWICH PHARMA CLARITHROMYCIN- HEXAL 250 CLARITHROMYCIN- HEXAL 500 COVERON PLUS BIADEXUM BIARTENSYL PREXUM PLUS HELM CYPROTERONE ACETATE 2,00 MG ETHINYLESTRADIOL 0,035 MG 38/20.1.1/0075 BODENE FRESENIUS- CEFTRIAXONE 2 G 38/20.1.1/0076 BODENE FRESENIUS- CEFTRIAXONE 1 G 38/20.1.1/0077 BODENE FRESENIUS- CEFTRIAXONE 500 MG 38/20.1.1/0078 BODENE FRESENIUS- CEFTRIAXONE 250 MG CLARITHROMYCIN 250,0 CLARITHROMYCIN 500,0 PERINDOPRIL TERT- BUTYLAMINE 4,0 INDAPAMIDE 1,25 PERINDOPRIL TERT- BUTYLAMINE 4,0 INDAPAMIDE 1,25 PERINDOPRIL TERT- BUTYLAMINE 4,0 INDAPAMIDE 1,25 PERINDOPRIL TERT- BUTYLAMINE 4,0 INDAPAMIDE 1,25 CYPROTERONE ACETATE 2,0 ETHINYLESTRADIOL 0,035 EACH VIAL CEFTRIAXONE 2000,0 EACH VIAL CEFTRIAXONE 1000,0 EACH VIAL CEFTRIAXONE 500,0 EACH VIAL CEFTRIAXONE 250,0 12.22 Notification of registration 3 Jun 2005v3.doc - Feb 2006 Page 7 of 11
38/1.2/0090 SANDOZ SANDOZ-CITALOPRAM 20 CITALOPRAM HYDROBROMIDE CITALOPRAM 20,0 38/1.2/0091 SANDOZ SANDOZ-CITALOPRAM 40 CITALOPRAM HYDROBROMIDE CITALOPRAM 40,0 38/20.2.8/0128 CIPLA-MEDPRO (PTY) ACITAB-400 DT ACYCLOVIR 400,0 38/20.2.8/0129 CIPLA-MEDPRO (PTY) ACITAB-200 DT ACYCLOVIR 200,0 38/20.2.8/0130 CIPLA-MEDPRO (PTY) ACITAB-800 DT 38/20.1.1/0131 CIPLA LIFE SCIENCES 38/20.1.1/0132 CIPLA LIFE SCIENCES CIPLA-CEFUROXIME- 500 CIPLA-CEFUROXIME- 250 38/34/0171 DONMED NUVARING 38/20.1.1/0174 RANBAXY (SA) KLARITHRAN SUSPENSION 125 MG/5 38/20.1.1/0175 RANBAXY (SA) KLARITHRAN SUSPENSION 250 MG/5 38/15.4/0185 ARROW PHARMA OCUPROST SOUTH AFRICA (PTY) 38/2.2/0190 TRIOMED ASPEN MIDAZOLAM 50 MG/10 38/3.1/0288 38/3.1/0289 ADCO-CLOFELAM 25 ADCO-CLOFELAM 50 38/21.2/0315 SANDOZ SANDOZ-GLIMEPIRIDE 1 ACYCLOVIR 800,0 CEFUROXIME AXETIL CEFUROXIME 500,0 CEFUROXIME AXETIL CEFUROXIME 250,0 EACH RING ETONOGESTREL 11,7 ETHINYL ESTRADIOL 2,7 EACH 5,0 ml SUSPENSION CLARITHROMYCIN 125,0 EACH 5,0 ml SUSPENSION CLARITHROMYCIN 250,0 EACH 1,0 ml SOLUTION LATANOPROST 50,0 ug EACH 10,0 ml SOLUTION MIDAZOLAM MIDAZOLAM 50,0 DICLOFENAC POTASSIUM 25,0 DICLOFENAC POTASSIUM 50,0 GLIMEPIRIDE 1,0 38/21.2/0316 SANDOZ SANDOZ-GLIMEPIRIDE 2 37/21.2/0317 SANDOZ SANDOZ-GLIMEPIRIDE 3 38/21.2/0318 SANDOZ SANDOZ-GLIMEPIRIDE 4 GLIMEPIRIDE 2,0 GLIMEPIRIDE 3,0 GLIMEPIRIDE 4,0 12.22 Notification of registration 3 Jun 2005v3.doc - Feb 2006 Page 8 of 11
A38/8.3/0391 A38/21.2/0432 A38/21.2/0433 A38/21.2/0434 A38/5.10/0435 A38/5.10/0436 ROCHE PRODUCTS CIPLA LIFE SCIENCES CIPLA LIFE SCIENCES RECORMON 60 000 FOR EACH CARTRIDGE RECO-PEN EPOETIN BETA 60 000,0 iu ADCO-GLIMEPIRIDE 1 GLIMEPIRIDE 1,0 ADCO-GLIMEPIRIDE 2 GLIMEPIRIDE 2,0 ADCO-GLIMEPIRIDE 4 GLIMEPIRIDE 4,0 CIPLA-ONDANSETRON 4 ONDANSETRON CIPLA-ONDANSETRON 8 ONDANSETRON 4,0 ONDANSETRON ONDANSETRON 8,0 A38/5.10/0437 CIPLA MEDPRO (PTY) ZANTRON-4 A38/5.10/0438 CIPLA MEDPRO (PTY) ZANTRON-8 A38/8.3/0499 ROCHE PRODUCTS RECORMON 500 IU/0,3 A38/8.3/0500 ROCHE PRODUCTS RECORMON 10 000 IU/0,6 A38/1.2/0520 ELI LILLY (SA) STRATTERA 10 MG EACH CAPSULE ATOMOXETINE ATOMOXETINE 10,0 A38/1.2/0521 ELI LILLY (SA) STRATTERA 18 MG EACH CAPSULE ATOMOXETINE ATOMOXETINE 18,0 A38/1.2/0522 ELI LILLY (SA) STRATTERA 25 MG EACH CAPSULE ATOMOXETINE ATOMOXETINE 25,0 A38/1.2/0523 ELI LILLY (SA) STRATTERA 40 MG EACH CAPSULE ATOMOXETINE ATOMOXETINE 40,0 A38/1.2/0524 ELI LILLY (SA) STRATTERA 60 MG EACH CAPSULE ATOMOXETINE ATOMOXETINE 60,0 A38/20.1.1/0550 A38/20.1.1/0551 TRIAXIPHIN 1 G TRIAXIPHIN 250 MG ONDANSETRON 4,0 ONDANSETRON 8,0 EACH SYRINGE EPOETIN BETA 500,0 iu EACH SYRINGE EPOETIN BETA 10 000,0 iu EACH VIAL CEFTRIAXONE 1000,0 EACH VIAL CEFTRIAXONE 250,0 12.22 Notification of registration 3 Jun 2005v3.doc - Feb 2006 Page 9 of 11
A38/20.1.1/0552 A38/20.1.1/0553 A38/20.1.1/0554 A38/20.1.1/0555 A38/1.2/0576 SANDOZ SANDOZ PAROXETINE 20 A39/2.7/0059 TRIAXIPHIN 500 MG EACH VIAL CEFTRIAXONE 500,0 KOCEF-250 EACH VIAL CEFTRIAXONE 250,0 KOCEF-500 EACH VIAL CEFTRIAXONE 500,0 KOCEF-1000 EACH VIAL CEFTRIAXONE 1000,0 PAROXETINE PAROXETINE 20,0 PANADO MELTABS PARACETAMOL 500,0 A39/2.7/0060 PANADO CHILDREN MELTABS PARACETAMOL 125,0 A39/2.7/0061 A39/8.3/0105 ROCHE PRODUCTS PANADO CHILDREN MELTABS EXTRA STRENGTH RECORMON 30 000 IU/0,6 PARACETAMOL 250,0 EACH SYRINGE EPOETIN BETA 30 000,0 iu A39/20.1.1/0125 A39/20.1.1/0126 A39/20.1.1/0127 GENERIX INTERNATIONAL SA GENERIX INTERNATIONAL SA GENERIX INTERNATIONAL SA TAZIJECT 0,5 G TAZIJECT 1,0 G TAZIJECT 2,0 G A39/20.2.8/0262 PHARMACARE ASPEN NEVIRAPINE SUSPENSION A39/5.10/0462 GENERIX INTERNATIONAL SA NAUSETRON 4 MG/2 INJECTION EACH VIAL CEFTAZIDIME PENTAHYDRATE EQUIVALENT TO CEFTAZIDIME 0,5 g EACH VIAL CEFTAZIDIME PENTAHYDRATE EQUIVALENT TO CEFTAZIDIME 1,0 g EACH VIAL CEFTAZIDIME PENTAHYDRATE EQUIVALENT TO CEFTAZIDIME 2,0 g EACH 5,0 ml SUSPENSION NEVIRAPINE HEMIHYDRATE NEVIRAPINE 50,0 EACH 2 ml AMPOULE ONDANSETRON DIHYDRATE ONDANSETRON 4 12.22 Notification of registration 3 Jun 2005v3.doc - Feb 2006 Page 10 of 11
A39/5.10/0463 GENERIX INTERNATIONAL SA NAUSETRON 8 MG/4 INJECTION EACH 4 ml AMPOULE ONDANSETRON DIHYDRATE ONDANSETRON 8 REGISTRAR OF MEDICINES DR ZOKUFA 12.22 Notification of registration 3 Jun 2005v3.doc - Feb 2006 Page 11 of 11